FORMULATIONS OF A PI3K/MTOR-INHIBITOR FOR INTRAVENOUS ADMINISTRATION

The present invention relates to a pharmaceutical aqueous formulation comprising -(4-{[4-(dimethylamino)piperidin-1-yl]carbonyl}phenyl)-3-[4-(4,6-dimorpholin-4-yl-,3,5-triazin-2-yl)phenyl]urea, or a pharmaceutically acceptable salt thereof, that is a clear solution. Such a formulation is particularl...

Full description

Saved in:
Bibliographic Details
Main Authors Harper Aidan James, Lillis Jonathan Richard, Cram Michael, Huang W. James, Luthra Sumit, Back Kevin Richard, Lukas Timothy Michael
Format Patent
LanguageEnglish
Published 21.12.2017
Subjects
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
Online AccessGet full text

Cover

Abstract The present invention relates to a pharmaceutical aqueous formulation comprising -(4-{[4-(dimethylamino)piperidin-1-yl]carbonyl}phenyl)-3-[4-(4,6-dimorpholin-4-yl-,3,5-triazin-2-yl)phenyl]urea, or a pharmaceutically acceptable salt thereof, that is a clear solution. Such a formulation is particularly suitable for intravenous or parenteral administration to a patient.
AbstractList The present invention relates to a pharmaceutical aqueous formulation comprising -(4-{[4-(dimethylamino)piperidin-1-yl]carbonyl}phenyl)-3-[4-(4,6-dimorpholin-4-yl-,3,5-triazin-2-yl)phenyl]urea, or a pharmaceutically acceptable salt thereof, that is a clear solution. Such a formulation is particularly suitable for intravenous or parenteral administration to a patient.
Author Cram Michael
Lillis Jonathan Richard
Harper Aidan James
Huang W. James
Lukas Timothy Michael
Back Kevin Richard
Luthra Sumit
Author_xml – fullname: Harper Aidan James
– fullname: Lillis Jonathan Richard
– fullname: Cram Michael
– fullname: Huang W. James
– fullname: Luthra Sumit
– fullname: Back Kevin Richard
– fullname: Lukas Timothy Michael
BookMark eNrjYmDJy89L5WRwcfMP8g31cQzx9PcLVvB3U3BUCPA09tb3DfEP0vX08_B08gSyFICqFDz9QoIcw1z9_EODFRxdfD39PIOBAiCNPAysaYk5xam8UJqbQdnNNcTZQze1ID8-tbggMTk1L7UkPjTYyMDQ3NjMwNLY1NHQmDhVAFaHLuY
ContentType Patent
DBID EVB
DatabaseName esp@cenet
DatabaseTitleList
Database_xml – sequence: 1
  dbid: EVB
  name: esp@cenet
  url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP
  sourceTypes: Open Access Repository
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Chemistry
Sciences
ExternalDocumentID US2017360935A1
GroupedDBID EVB
ID FETCH-epo_espacenet_US2017360935A13
IEDL.DBID EVB
IngestDate Fri Jul 19 12:49:18 EDT 2024
IsOpenAccess true
IsPeerReviewed false
IsScholarly false
Language English
LinkModel DirectLink
MergedId FETCHMERGED-epo_espacenet_US2017360935A13
Notes Application Number: US201515534999
OpenAccessLink https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20171221&DB=EPODOC&CC=US&NR=2017360935A1
ParticipantIDs epo_espacenet_US2017360935A1
PublicationCentury 2000
PublicationDate 20171221
PublicationDateYYYYMMDD 2017-12-21
PublicationDate_xml – month: 12
  year: 2017
  text: 20171221
  day: 21
PublicationDecade 2010
PublicationYear 2017
RelatedCompanies Pfizer Inc
RelatedCompanies_xml – name: Pfizer Inc
Score 3.1289933
Snippet The present invention relates to a pharmaceutical aqueous formulation comprising...
SourceID epo
SourceType Open Access Repository
SubjectTerms CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
Title FORMULATIONS OF A PI3K/MTOR-INHIBITOR FOR INTRAVENOUS ADMINISTRATION
URI https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20171221&DB=EPODOC&locale=&CC=US&NR=2017360935A1
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3dS8MwED_GFPVNp-LHlIDSt7Kmn9vDkK4fLGrbsbVjb6NZMxCkG67iv--lTt3T3i6fXAKXyy-XuwN4NKkQjr7UVC23TdXMNU3tLm1LtRxKC4MuHIPL944otoeZ-TyzZg14__WFqeOEftXBEVGiFijvVX1er_8fsfz6b-Wmw9-wavUUpn1f2aJj6lBdp4o_6AejxE88xfP62USJx3WbYUurn4tY6UBepGWk_WA6kH4p612lEp7C4QjnK6szaIiyBcfeb-61FhxFW5M3klvp25yDj4gtyl5_PH9JEhKXjJjx0onSZKyyeMgGDCmCvQiL07E7DeIkmxDXj1jMZHJkOfACHsIg9YYqsjP_W_08m-zyblxCs1yV4goI73Ir54Wed23LLGivJxCdOM6yMARHVLO4hva-mW72N9_CiSzKnxs6bUOz-vgUd6h_K35fb9s398CCfQ
link.rule.ids 230,309,786,891,25594,76904
linkProvider European Patent Office
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3dT8IwEL8QNOKbokYUtYlmbwvrvgoPxIx9ZBW2EdgIb2RlIzExg8iM_77tBOWJt6bXXq5NrpffXe8O4EXHeU7UlSIrqanLeqoocndlGrJBMM40vCQaE_6OIDT9RH-bG_MafOxzYao6od9VcUSuUUuu72X1Xm_-nVhO9bdy22HvfGr96sV9R9qhY0ywqmLJGfTdceREtmTb_WQqhZOKppki6mdxrHRCOCgUlfbd2UDkpWwOjYp3Aadjzq8oL6GWF01o2Pvea004C3Yhbz7cad_2ChyO2IJk9Jv5iyIPWWhMtWEniKOJTEOfDigfIb4K0TCeWDM3jJIpspyAhlQ0RxYbr-HZc2Pbl7k4i7_TL5LpoezaDdSLdZHfAmJdZqQsU9OuaegZ7vVyjk4IWWVazjiqWbagfYzT3XHyEzT8OBgtRjQc3sO5IIlfHCpuQ738_MofuC0u2WN1hT84K4Vo
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=FORMULATIONS+OF+A+PI3K%2FMTOR-INHIBITOR+FOR+INTRAVENOUS+ADMINISTRATION&rft.inventor=Harper+Aidan+James&rft.inventor=Lillis+Jonathan+Richard&rft.inventor=Cram+Michael&rft.inventor=Huang+W.+James&rft.inventor=Luthra+Sumit&rft.inventor=Back+Kevin+Richard&rft.inventor=Lukas+Timothy+Michael&rft.date=2017-12-21&rft.externalDBID=A1&rft.externalDocID=US2017360935A1